The clinical representative stated that the implanting clinician had not provided a treatment plan, and no further information was available.The clinical representative noted that the implanting clinician was unsure of what might have caused the erosion.A stimwave representative conducted a review of sterilization and packaging records for the respective product lot; stimwave has confirmed that the product was delivered sterile, validated sterilization parameters were used, and sterile barriers were verified to be intact following packaging.Based on this information, the device erosion was confirmed/replicated.There is no evidence that the product did not meet specifications.The cause of the erosion is unknown/no problem found.Design fmea for stimq (b)(4) and hra for stimq (b)(4) was reviewed and erosion is a known issue with mitigation controls in place to reduce risk as far as possible and no corrective action is required.
|